Molecular dissection of abnormal wound healing processes resulting in keloid disease
- PMID: 20002895
- DOI: 10.1111/j.1524-475X.2009.00553.x
Molecular dissection of abnormal wound healing processes resulting in keloid disease
Abstract
Keloids are locally aggressive scars that typically invade into healthy surrounding skin and cause both physical and psychosocial distress to the patient. These pathological scars occur following minimal skin trauma after a variety of causes including burns and trauma. Although the pathogenesis of keloid disease is not well understood, it is considered to be the end product of an abnormal healing process. The aim of this review was to investigate the molecular and cellular pathobiology of keloid disease in relation to the normal wound healing process. The molecular aberrances in keloids that correlate with the molecular mechanisms in normal wound healing can be categorized into three groups: (1) extracellular matrix proteins and their degradation, (2) cytokines and growth factors, and (3) apoptotic pathways. With respect to cellular involvements, fibroblasts are the most well-studied cell population. However, it is unclear whether the fibroblast is the causative cell; they are modulated by other cell populations in wound repair, such as keratinocytes and macrophages. This review presents a detailed account of individual phases of the healing process and how they may potentially be implicated in aberrant raised scar formation, which may help in clarifying the mechanisms involved in keloid disease pathogenesis.
Similar articles
-
Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management.Curr Opin Pediatr. 2006 Aug;18(4):396-402. doi: 10.1097/01.mop.0000236389.41462.ef. Curr Opin Pediatr. 2006. PMID: 16914994 Review.
-
Macrophages in skin injury and repair.Immunobiology. 2011 Jul;216(7):753-62. doi: 10.1016/j.imbio.2011.01.001. Epub 2011 Jan 8. Immunobiology. 2011. PMID: 21281986 Review.
-
Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.Acta Derm Venereol. 2005;85(3):216-20. doi: 10.1080/00015550410025453. Acta Derm Venereol. 2005. PMID: 16040405
-
The molecular basis of keloid and hypertrophic scar formation.Mol Med Today. 1998 Jan;4(1):19-24. doi: 10.1016/S1357-4310(97)80541-2. Mol Med Today. 1998. PMID: 9494966 Review.
-
Stat3 contributes to keloid pathogenesis via promoting collagen production, cell proliferation and migration.Oncogene. 2006 Aug 31;25(39):5416-25. doi: 10.1038/sj.onc.1209531. Epub 2006 Apr 17. Oncogene. 2006. PMID: 16619044
Cited by
-
Potent dual inhibitors of TORC1 and TORC2 complexes (KU-0063794 and KU-0068650) demonstrate in vitro and ex vivo anti-keloid scar activity.J Invest Dermatol. 2013 May;133(5):1340-50. doi: 10.1038/jid.2012.483. Epub 2013 Jan 10. J Invest Dermatol. 2013. PMID: 23303455 Free PMC article.
-
Nonmuscle Myosin II Activation Regulates Cell Proliferation, Cell Contraction, and Myofibroblast Differentiation in Keloid-Derived Fibroblasts.Adv Wound Care (New Rochelle). 2020 Sep;9(9):491-501. doi: 10.1089/wound.2019.0944. Epub 2020 Jan 14. Adv Wound Care (New Rochelle). 2020. PMID: 32941122 Free PMC article.
-
Site-specific keloid fibroblasts alter the behaviour of normal skin and normal scar fibroblasts through paracrine signalling.PLoS One. 2013 Dec 9;8(12):e75600. doi: 10.1371/journal.pone.0075600. eCollection 2013. PLoS One. 2013. PMID: 24348987 Free PMC article.
-
High Efficiency In Vitro Wound Healing of Dictyophora indusiata Extracts via Anti-Inflammatory and Collagen Stimulating (MMP-2 Inhibition) Mechanisms.J Fungi (Basel). 2021 Dec 20;7(12):1100. doi: 10.3390/jof7121100. J Fungi (Basel). 2021. PMID: 34947082 Free PMC article.
-
Regeneration of Dermis: Scarring and Cells Involved.Cells. 2019 Jun 18;8(6):607. doi: 10.3390/cells8060607. Cells. 2019. PMID: 31216669 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources